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Background: The assessment of the embryo quality is crucial to maintain an high pregnancy rate and to reduce
the risk of multiple pregnancy. The evaluation of the pronuclear and nucleolar characteristics of human zygote have
been proposed as an indicator of embryo development and chromosomal complement. The aim of the current
study was to assess the role of pronuclear morphology evaluation in vitro fertilization (IVF) / intracytoplasmic sperm
injection (ICSI) cycles.
Methods: Retrospective clinical analysis on 755 non-elective transfers of only one embryo (ET). Embryo assessment
was performed in days 1 and 2. Clinical and biological data were recorded and analyzed according to embryo and/
or pronuclear morphology.
Results: Both pronuclear and embryo morphology were significantly related to clinical pregnancy and live-birth
rates. No significant difference in clinical pregnancy and live-birth rates was detected when the pronuclear and
embryo morphology assessments were combined. Embryo morphology and maternal age were the only
independent predictors of favorable outcome by logistic regression analysis.
Conclusions: Pronuclear evaluation is effective to select the best zygotes if ET is performed at day 1, whereas it did
not improve the clinical outcomes when combined with embryo morphology evaluation in day 2.
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The selection of the best embryo(s) to transfer is a cru-
cial point in in vitro fertilization (IVF)/ intracytoplasmic
sperm injection (ICSI) procedures to maintain a high
performance in terms of pregnancy rate and to reduce
the risk of multiple pregnancies.
Several methodologies have been proposed and employed
for embryo selection, but their clinical efficacy is still
extremely debated and considered suboptimal [1-3].* Correspondence: nicoli.alessia@asmn..re.it
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reproduction in any medium, provided the orThe study of the pronuclear and nucleolar characteris-
tics of human zygote has been proposed as an indicator
of embryo development and competence [4-10]. Previ-
ous data have suggested that zygote-score could be an
efficient tool for embryo selection if combined with
embryo morphology evaluation on days 2 and 3 [10,11].
In particular, the morphological characteristics of the
human zygote may suggest an increased risk of arrest of
the embryo [11]. Moreover, to date, there is not defini-
tive consensus about the clinical efficacy of the zygote
pronuclear morphology. In fact, other Authors suggested
that embryo morphology has a better prognostic value
than zygote-score in embryo selection [12-14], and that
pronuclear scoring system has any advantage to evaluate
embryo quality [15].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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aimed to evaluate if the pronuclear morphology evalu-
ation improves the clinical outcomes in IVF/ICSI when
combined with embryo morphology assessment.Materials and methods
Patients
The current was a non-interventional, retrospective sin-
gle centre review.
Institutional Review Board approval was not required
since all couples included underwent a routine IVF/ICSI
program in our Reproductive Unit, and no additional/
experimental intervention was performed.
All IVF/ICSI cycles performed between April 2008 and
November 2010 were reviewed.
All cycles characterized by the transfer of one embryo
were selected and included in the final analysis. Were
excluded cycles in which with more than one oocyte was
fertilized and cleaved.
For any cycle we collected all available clinical and bio-
logical data. Specifically, we recorded the patients' charac-
teristics, the controlled ovarian stimulation regimens, the
drugs and protocols used for luteal phase support, the
characteristics of oocytes retrieved and embryos transfer,
the pronuclear and embryo morphology. Implantation,
pregnancy, abortion and live-birth rates were also noted.Ovarian stimulation and oocyte retrieval
In all cases the controlled ovarian stimulation was
achieved using individualized protocols of recombinant-
follicle stimulating hormone (rFSH; Gonal F, Serono,
Rome, Italy) in down-regulated cycles. A serum estra-
diol concentrations <50 pg/mL and an absence of folli-
cles having a mean diameter higher than 10 mm were
considered as criteria for gonadotropin administration.
The ovarian response was monitored by use of serum
estradiol assays and serial ultrasonographies.
In presence of at least one follicle with a mean diam-
eter equal or higher than 17 mm was observed, 10,000
IU human chorionic gonadotropin (hCG; Gonasi, IBSA,
Milan, Italy) or 250 μg recombinant hCG (Ovitrelle,
Serono, Rome, Italy) were intramuscularly administered.
Oocyte retrieval was performed 34 to 36 hours after
hCG administration by ultrasound-guided transvaginal
aspiration.Semen preparation
Semen samples were collected by masturbation after 3–
5 days of abstinence. The preparation for conventional
IVF or ICSI was performed following the World Health
Organization standard protocol [16,17].Oocyte insemination
For the conventional IVF procedures, oocytes were cul-
tured individually and inseminated in microdrops of
fresh medium (Cook IVF, Melbourne, Australia) under
mineral oil with 100,000 activated spermatozoa. For ICSI
procedure, after the removal of the cumulus and corona
cells, oocytes nuclear maturation assessment was per-
formed using an inverted microscope to ensure the in-
jection of metaphase II oocytes exclusively [18].Assessment of fertilization/cleavage
Oocyte fertilization was assessed at 18–20 hours (day 1)
from insemination/injection and confirmed by the pres-
ence of 2 pronuclei (2PN) and the alignment of nucleolar
precursor bodies (NPB). At same time, the pronuclear
morphological score was assessed [4]. The observation
of 2PN was performed using an inverted microscope
with Hoffman modulation contrast at ×400 magnification
(TE 2000 U, Nikon Corp., Japan). Zygotes with simultan-
eously juxtaposed and centralized PN, nucleoli of large
size and orientated, and orientation of polar bodies in
the longitudinal axis of PN were classified as Z1 and
considered as the best zygote morphology [4,5,19].
Zygotes having all other configurations were classified
as Z2.
ET was performed after 48 hrs (day 2) of embryo cul-
ture. During embryo observation five parameters were
classified: cleavage symmetry, blastomere shape and size,
cytoplasmic aspect, presence of fragmentation and of
blastomere multi/micronucleation. Embryos characterized
by symmetric cleavage, regular blastomeres sheep and
size, absence of any cytoplasmic anomalies such as dark
areas, granulations and vacuole, blastomeres multinuclea-
tion (≥ 2 nuclei per blastomere) or micronucleation were
considered as grade I embryos. Grade II embryos pre-
sented slightly irregular blastomeres sheep and size, frag-
mentation ≤ 10%, and small cytoplasmic vacuoles. Grade
III embryos were characterized by asymmetric cleavage,
highly irregular blastomeres sheep and size, fragmentation
among 10-30%, dark cytoplasm, cytoplasmic vacuoles and
multinucleation. Finally, grade IV embryos displayed
asymmetric cleavage, severe irregular blastomeres sheep
and size, fragmentation among 30-50%, dark cytoplasm
with massive presence of vacuoles. ETs of grades I and II
embryos were defined as High Quality Embryo ET (HQE
ET), whereas ETs of grades III and IV embryos as Poor
Quality Embryo ET (PQE ET).Embryo transfer and establishment of pregnancy
All patients received intramuscular (100 mg/day; Pron-
togest; IBSA, Milan, Italy) or transvaginal supplemental
progesterone (600 mg/day; Prometrium, Rottapharm,
Milan, Italy) for 15 days.
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12 days after ET by a positive quantitative serum β-hCG
assay >10 IU. In case of positive pregnancy test, the hor-
monal support was continued until 35 days after the ET.
Clinical pregnancy was defined as one embryo with
heart beat revealed by transvaginal ultrasonography at 5
weeks after ET. Because of only one embryo was trans-
ferred in each ET, the clinical pregnancy was equivalent
to the embryo implantation.Statistical analysis
The normal distribution of continuous variables was
evaluated with the use of the Kolmogrov-Smirnov test,
and continuous data were expressed as the mean ±
standard deviation (SD).
Continuous data were analyzed by Student t test for
unpaired data. For categorical variables, the Pearson Chi
square test was performed; Fisher’s exact test was used
for the frequency tables when more than 20% of the
expected values were lower than five.
To investigate which of the variables studied could
best predict the chances of a clinical pregnancy and live-
birth, a binary logistic regression was performed, usingTable 1 Clinical outcomes analyzed according to embryo and
HQE ET
(n., %)
Total cycles 450, 59.6
Maternal age (years) 36.83±3.88
Clinical pregnancy rate 44^/450, 9.8
Singleton 42/44, 95.5*
Implantation rate 44/450, 9.8
Abortion rate 9/44, 20.5
Live-birth rate 34/450, 7.6
Gestational age at birth (weeks) 37.8±4.2
Birth weight (gr) 2979.3±798.3
Z1 ET
(n., %)
Total cycles 139
Maternal age (years) 36.22±3.71
Excellent quality embryos 105/139, 75.5
Clinical pregnancy rate 16^/139, 12.2
Singleton 16/16, 100.0
Implantation rate 16/139, 11.5
Abortion rate 2/16, 12.5
Live-birth rate 13/139, 9.4
Gestational age at birth (weeks) 37.3±5.1
Birth weight (gr) 2959.6±849.7
^: one ectopic pregnancy; *: two sets of monozygotic twins.embryo quality, insemination technique and pronuclear
morphology as predictors.
For all tests, the statistical significance level was set at
P < 0.05.
Analysis was performed using SPSS version 20 for
Microsoft Office.
Results
In the study period, 2,212 IVF/ICSI cycles were screened
and 755 cycles (755/2,212, 34.2%) were included in the
final analysis. Specifically, 293 and 462 cycles of IVF
(293/755, 38.8%) and ICSI (462/755, 61.2%) programs
were studied, respectively. One thousand and two hun-
dred five cycles (1.205/2.212, 54.4%) were excluded be-
cause of more then one embryo was transferred, and
252 cycles (252/2.212, 11.4%) because of ET was not
performed for fertilization failure or cryopreservation of
all oocytes/embryos.
A statistically significant higher clinical pregnancy [17/
139 (12.2%) vs. 39/616 (6.3%); P = 0.017] and live-birth
[13/139 (9.4%) vs. 30/616 (4.9%); P = 0.039] rates were
observed in ETs with embryos derived from Z1 zygotes
(Z1 ETs) compared to ETs with embryos derived from
Z2 zygotes (Z2 ETs). Similarly, a statistically significantpronuclear morphologies
PQE ET P value
(n., %)
305, 40.4
36.48±4.04 0.234
11/305, 3.6 0.001
11/11, 100.0 0.471
11/305, 3.6 0.001
2/11, 18.2 0.866
9/305, 3.0 0.007
39.6±1.3 0.213
3214.6±391.0 0.399
Z2 ET
(n., %)
616
36.79±3.99 0.123
345/616, 56.0 <0.001
39/616, 6.3 0.017
37/39, 94.9* 0.356
39/616, 6.3 0.034
9/39, 23.1 0.712
30/616, 4.9 0.039
38.5±3.1 0.351
3058.4±692.2 0.691
Table 2 Clinical pregnancy and live-birth rate analyzed according to pronuclear and embryo morphology
Clinical pregnancy rate Live-birth rate
No Yes Total No Yes Total
(n., %) (n., %) (n., %) (n., %) (n., %) (n., %)
HQE ET Z1 90, 85.7 15, 14.3 105, 100 93, 88.6 12, 11.4 105, 100
Z2 316, 91.6 29, 8.4 345, 100 323, 93.6 22, 6.4 345, 100
PQE ET Z1 32, 94.1 2, 5.9 34, 100 33, 97.1 1, 2.9 34, 100
Z2 262, 96.7 9, 3.3 271, 100 263, 97.0 8, 3.0 271, 100
Total 700, 92.7 55, 7.4 755, 100 712, 94.3 43, 5.7 755, 100
The distribution pronuclear and embryo morphology was significantly (P < 0.05) different between patients who had and who did not had a clinical pregnancy
and a live-birth.
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(3.6%); P = 0.001] and live-birth [34/450 (7.6%) vs. 9/305
(3.0%); P = 0.007] rates were observed in HQE ETs com-
pared to PQE ETs (Table 1).
In Table 2 are showed the clinical pregnancy and live-birth
rates per ETaccording to PN and embryo morphology.
The distribution of PN and embryo morphology was
significantly different (P < 0.05) between patients who
had and who did not had a clinical pregnancy and/or a
live-birth (Table 2). The HQE-Z1 and PQE-Z2 ETs
showed, respectively, the highest and lowest clinical
pregnancy and live-birth rates (Table 2). No significant
difference between HQE-Z1 and HQE-Z2 ETs and be-
tween PQE-Z1 and PQE-Z2 ETs was detected in clinical
pregnancy (P = 0.093 and P = 0.450 for HQE-Z1 vs. HQE-
Z2 ETs and for PQE-Z1 vs. PQE-Z2 ETs, respectively) andTable 3 Regression analysis using maternal age, embryo qual
as predictors of clinical pregnancy and delivery
B ES
Constant
Clinical pregnancy −3.845 0.374
Delivery −4.084 0.417
Maternal age
Clinical pregnancy 1.263 0.290
Delivery 1.282 0.326
Insemination technique
Clinical pregnancy 0.021 0.304
Delivery 0.074 0.341
Pronuclear morphology
Clinical pregnancy 0.481 0.320
Delivery 0.468 0.359
Embryo quality
Clinical pregnancy 1.078 0.353
Delivery 0.974 0.391
Model for clinical pregnancy prediction: χ2(4) = 33.445; P < 0.001; R2 = 0.106.
Model for delivery prediction: χ2(4) = 25.200; P < 0.001; R2 = 0.093.live-birth rates (P = 0.086 and P = 0.997 for HQE-Z1 vs.
HQE-Z2 ETs and for PQE-Z1 vs. PQE-Z2 ETs, respect-
ively) (Table 2).
Finally, using the binary logistic regression to evaluate
the best predictor of clinical pregnancy and live-birth
only the embryo morphology and the maternal age
resulted independent predictors (Table 3).
Discussion
To date, the evaluation of pronuclear and embryo morph-
ologies is a common practice in ART laboratories to select
the best embryos to transfer. Even if several data regarding
the clinical efficacy of pronuclear morphology evaluation
have published [4-13,17], the current is the first clinical
study reporting reproductive data of patients submitted to
the transfer of one embryo because of only one oocyte wasity, insemination technique and pronuclear morphology
P OR 95% CI
Lower Upper
<0.001 0.021
<0.001 0.017
<0.001 3.535 2.002 6.244
<0.001 3.604 1.904 6.821
0.946 1.021 0.562 1.854
0.828 1.077 0.552 2.099
0.132 1.618 0.865 3.029
0.192 1.597 0.791 3.227
0.002 2.938 1.470 5.871
0.013 2.648 1.231 5.698
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Salumets et al. [20] included in their analysis reproductive
data of a single embryo transferred, even if this was “elect-
ive” [20].
The analysis of this specific cohort of patients permit-
ted to exclude a priori the bias of embryo selection per-
formed by the operator, even if the overall ART clinical
outcomes were, as expected, very poor.
Firstly, our data suggest that both pronuclear and embryo
morphology evaluations have a prognostic value in the
prediction of clinical pregnancy in IVF/ICSI procedures.
Specifically, our data confirm the efficacy of the pronuclear
morphology evaluation to predict the clinical pregnancy
[4-11,21]. At this regard, current findings highlight that the
pronuclear morphology is an important tool not only to in-
dividuate abnormal fertilizations (only 1 PN or more than 2
PN) but to select zygotes when ET is performed at day 1, as
recently recommended by the European Society of Human
Reproduction and Embryology (ESHRE) [1].
Secondly, even if the HQE-Z1 and PQE-Z2 ETs resulted
respectively closely related to the highest and lowest repro-
ductive performances, the pronuclear morphology evalu-
ation seemed to give limited additional information for the
selection of the embryos to transfer at day 2 [22]. The un-
effectiveness of the pronuclear morphology evaluation to
improve the embryo selection was observed both in case of
high- and low-quality embryos. In fact, the reproductive
outcomes did not change after ET of embryos with the
same quality deriving from zygotes of different morph-
ology, i.e. HQE-Z1 vs. HQE-Z2 and PQE-Z1 vs. PQE-Z2.
Finally, our findings demonstrate by binary logistic re-
gression analysis that, after correction for confounders, only
the embryo morphology evaluation at day 2 resulted an in-
dependent predictors of clinical pregnancy and live-birth.
In conclusion, the current study confirm that pronuclear
morphology evaluation is effective to assess the oocyte
fertilization and to select the best zygotes if ET is per-
formed at day 1, and suggest that its role for selecting the
best embryo to transfer at day 2 is limited. Probably, as
suggested by Montag et al. [23], the process of pronuclear
formation is a highly dynamic mechanism, hardly resalable
in a static evaluation. Further randomized controlled clin-
ical trials on well selected population are needed to con-
firm or deny our conclusions.Competing interests
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